Claudia Del Fante Selected Research

Photopheresis

1/2022	Mechanisms of Action of Extracorporeal Photopheresis in the Control of Bronchiolitis Obliterans Syndrome (BOS): Involvement of Circulating miRNAs.
6/2021	Photopheresis Abates the Anti-HLA Antibody Titer and Renal Failure Progression in Chronic Antibody-Mediated Rejection.
2/2018	Reflections on the usefulness of extracorporeal photopheresis in renal transplant rejection: A concise review of the involved mechanisms and therapeutic perspectives.
2/2017	Extracorporeal photopheresis for bronchiolitis obliterans syndrome after allogeneic stem cell transplant: An emerging therapeutic approach?
1/2016	Comparison of two automated mononuclear cell collection systems in patients undergoing extracorporeal photopheresis: a prospective crossover equivalence study.
9/2013	Mononuclear cell collection for extracorporeal photochemotherapy: a study comparing an automatic and a semiautomatic apheresis device.
9/2012	Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications.
6/2010	Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients.
10/2004	Intensive extracorporeal photochemotherapy for severe acute hepatic graft-versus-host disease.
7/2003	Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudia Del Fante Research Topics

Disease

6	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2021 - 07/2003
6	Wounds and Injuries (Trauma) 02/2018 - 02/2011
4	COVID-19 08/2022 - 01/2020
4	Bronchiolitis Obliterans Syndrome 01/2022 - 06/2010
2	Infections 01/2020 - 11/2014
2	Skin Ulcer 03/2016 - 01/2014
2	Ulcer 10/2013 - 04/2012
1	Critical Illness (Critically Ill) 08/2022
1	Proteinuria 06/2021
1	Renal Insufficiency (Renal Failure) 06/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Breakthrough Infections 01/2020
1	Inflammation (Inflammations) 01/2019
1	Autoimmune Diseases (Autoimmune Disease) 02/2018
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 05/2015
1	Hemophilia A (Haemophilia) 01/2014
1	Pain (Aches) 10/2013
1	Chronic Limb-Threatening Ischemia 10/2013
1	Stomatitis 02/2013
1	Myocardial Infarction 01/2012
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2012
1	Parkinson Disease (Parkinson's Disease) 01/2012
1	Mucositis 09/2011
1	Hemolysis 02/2006
1	Pre-Eclampsia (Preeclampsia) 02/2006
1	HELLP Syndrome 02/2006
1	Thrombotic Microangiopathies 02/2006
1	Immunoglobulin Light-chain Amyloidosis 11/2005

Drug/Important Bio-Agent (IBA)

4	ChitosanIBA 02/2018 - 02/2011
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 02/2011
3	Silver Sulfadiazine (SSD)FDA LinkGeneric 02/2018 - 05/2013
2	Glutamic Acid (Glutamate)FDA Link 02/2018 - 05/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2014 - 05/2013
2	Ophthalmic Solutions (Eye Drops)IBA 02/2013 - 04/2012
1	MicroRNAs (MicroRNA)IBA 01/2022
1	AntibodiesIBA 06/2021
1	Interleukin-6 (Interleukin 6)IBA 06/2021
1	Neutralizing AntibodiesIBA 01/2021
1	C-Reactive ProteinIBA 12/2020
1	Viral DNAIBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	Sulfadiazine (Sulphadiazine)FDA Link 02/2018
1	AntioxidantsIBA 02/2018
1	Oleic Acid (Oleate)IBA 02/2018
1	alpha-Tocopherol FDA Link 02/2018
1	Tocopherols (Tocopherol)IBA 02/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Sericins (Sericin)IBA 03/2016
1	Phosphates (Orthophosphate)IBA 03/2016
1	fludarabineIBA 05/2015
1	Vancomycin FDA LinkGeneric 01/2014
1	PowdersIBA 01/2014
1	platelet-derived growth factor ABIBA 01/2014
1	AlginatesIBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2013
1	Lipid NanoparticlesIBA 05/2013
1	Silver CompoundsIBA 05/2013
1	CelluloseIBA 05/2013
1	SolutionsIBA 02/2013
1	UCON 50-HB-5100 (F127)IBA 09/2011
1	carbopol 940 (sodium polyacrylate)IBA 02/2011
1	EnzymesIBA 02/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2006

Therapy/Procedure

10	Photopheresis 01/2022 - 07/2003
6	Therapeutics 08/2022 - 01/2012
3	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2018 - 09/2013
2	Drug Therapy (Chemotherapy) 01/2020 - 11/2005
2	Hematopoietic Stem Cell Transplantation 01/2020 - 05/2015
2	Plasma Exchange 01/2014 - 02/2006
1	Artificial Respiration (Mechanical Ventilation) 12/2020
1	Surgical Amputation (Amputations) 10/2013
1	Transplantation 09/2013
1	Stem Cell Transplantation 07/2003